Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Riccucci (Siena, Italy), T. Wilkinson (Southampton, United Kingdom), S. Schembri (Dundee, United Kingdom), C. Brightling (Leicester, United Kingdom), N. Bakerly (Salford, United Kingdom), K. Lewis (Swansea, United Kingdom), W. Macnee (Edinburgh, United Kingdom), L. Rombo (Uppsala, Sweden), M. Allen (Stoke-on-Trent, United Kingdom), P. Walker (Liverpool, United Kingdom), D. Casula (Siena, Italy), P. Moris (Rixensart, Belgium), S. Schoonbroodt (Rixensart, Belgium), M. Testa (Siena, Italy), A. Arora (Siena, Italy). Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD). 264

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae (NTHi) infection of COPD lung tissue Source: Eur Respir J 2006; 28: Suppl. 50, 841s Year: 2006 Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Non-typeable Haemophilus influenzae infection of ciliated epithelium from healthy and chronic obstructive pulmonary disease donors Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 HI-164, an oral vaccine to non-typable haemophilus influenzae, reduces antibiotic use, respiratory exacerbations and hospitalisations in patients with COPD Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) and M. catarrhalis (Mcat) adjuvanted vaccines in adults Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation Source: ERJ Open Res, 7 (1) 00614-2020; 10.1183/23120541.00614-2020 Year: 2021 CD4+ T cell responses to non-encapsulated Haemophilus influenzae in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 350s Year: 2003 Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine Source: Eur Respir J 2002; 20: 813-818 Year: 2002 Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Safety and immunogenicity of hemophilus influenzae type B conjugate vaccine in COPD Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma Source: Eur Respir J, 56 (4) 2000194; 10.1183/13993003.00194-2020 Year: 2020 Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007 Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006 Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 The role of Moraxella catarrhalis in COPD Source: Annual Congress 2005 - COPD: role of infection Year: 2005 Haemophilus influenzae in COPD patients with poorer lung function carry more antibiotic resistance Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Specific immune response against Haemophilus influenzae in stable COPD Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010 Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012